Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 11, Novembre 2013
Page(s) 951 - 953
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20132911007
Publié en ligne 20 novembre 2013
  1. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011 ; 25 : 1895–1908. [CrossRef] [PubMed]
  2. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004 ; 18 : 1926–1945. [CrossRef] [PubMed]
  3. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011 ; 12 : 21–35. [CrossRef] [PubMed]
  4. Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 2009 ; 100 : 865–869. [CrossRef] [PubMed]
  5. Buzzai M, Bauer DE, Jones RG, et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005 ; 24 : 4165–4173. [CrossRef] [PubMed]
  6. Choo AY, Kim SG, Vander Heiden MG, et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell 2010 ; 38 : 487–499. [CrossRef] [PubMed]
  7. Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci USA 1998 ; 95 : 1511–1516. [CrossRef]
  8. Leprivier G, Remke M, Rotblat B, et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 2013 ; 153 : 1064–1079. [CrossRef] [PubMed]
  9. Ryazanov AG, Shestakova EA, Natapov PG. Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 1988 ; 334 : 170–173. [CrossRef] [PubMed]
  10. Browne GJ, Finn SG, Proud CG. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 2004 ; 279 : 12220–12231. [CrossRef] [PubMed]
  11. Foretz M, Taleux N, Guigas B, et al. Régulation du métabolisme énergétique par l’AMPK. Med Sci (Paris) 2006 ; 22 : 381–388. [CrossRef] [EDP Sciences] [PubMed]
  12. Julien LA, Roux P. mTOR, la cible fonctionnelle de la rapamycine. Med Sci (Paris) 2010 ; 26 : 1056–1060. [CrossRef] [EDP Sciences] [PubMed]